Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Necrotic or pathologically altered tissue plasma membrane phospholipid molecules refer to specific lipid components of the cell membrane that undergo structural and functional changes during necrosis or pathological cell death. The most notable among these is phosphatidylserine (PS), a glycerophospholipid normally confined to the inner leaflet of the plasma membrane in healthy cells. During necrosis, as well as other forms of regulated cell death (e.g., apoptosis, necroptosis), PS and potentially other phospholipids become exposed on the outer leaflet of the plasma membrane, serving as signals for immune recognition and clearance.
Targeting exposed phospholipids like PS has been explored for imaging dying tissues/tumors and developing therapies aimed at modulating immune responses associated with tissue damage/inflammation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Necrotic or Pathologically Altered Tissue Plasma Membrane Phospholipid Molecules.